Publicaciones en colaboración con investigadores/as de Centro Nacional de Microbiología (38)

2024

  1. Invasive Fungal Diseases in Adult Patients in Intensive Care Unit (FUNDICU): 2024 consensus definitions from ESGCIP, EFISG, ESICM, ECMM, MSGERC, ISAC, and ISHAM

    Intensive Care Medicine

2023

  1. Identification of Mycobacterium abscessus Subspecies by MALDI-TOF Mass Spectrometry and Machine Learning

    Journal of clinical microbiology, Vol. 61, Núm. 1, pp. e0111022

2022

  1. Cellular and Humoral Responses Follow-up for 8 Months after Vaccination with mRNA-Based Anti-SARS-CoV-2 Vaccines

    Biomedicines, Vol. 10, Núm. 7

2021

  1. Azole resistance survey on clinical Aspergillus fumigatus isolates in Spain

    Clinical Microbiology and Infection, Vol. 27, Núm. 8, pp. 1170.e1-1170.e7

  2. Induction of High Levels of Specific Humoral and Cellular Responses to SARS-CoV-2 After the Administration of Covid-19 mRNA Vaccines Requires Several Days

    Frontiers in Immunology, Vol. 12

  3. Invasive fusariosis in nonneutropenic patients, Spain, 2000-2015

    Emerging Infectious Diseases, Vol. 27, Núm. 1, pp. 26-35

  4. Mixinyeast: A multicenter study on mixed yeast infections

    Journal of Fungi, Vol. 7, Núm. 1, pp. 1-14

  5. Multicenter evaluation of the Panbio™ COVID-19 rapid antigen-detection test for the diagnosis of SARS-CoV-2 infection

    Clinical Microbiology and Infection, Vol. 27, Núm. 5, pp. 758-761

2020

  1. Effect of Influenza Vaccination Inducing Antibody Mediated Rejection in Solid Organ Transplant Recipients

    Frontiers in Immunology, Vol. 11

  2. Pre-existing Hemagglutinin Stalk Antibodies Correlate with Protection of Lower Respiratory Symptoms in Flu-Infected Transplant Patients

    Cell Reports Medicine, Vol. 1, Núm. 8

2019

  1. Executive summary of clinical practice guideline for the management of invasive diseases caused by Aspergillus: 2018 Update by the GEMICOMED-SEIMC/REIPI

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 37, Núm. 8, pp. 535-541

  2. Fluconazole resistance is not a predictor of poor outcome in patients with cryptococcosis

    Mycoses, Vol. 62, Núm. 5, pp. 441-449

  3. Improvement in detecting cytomegalovirus drug resistance mutations in solid organ transplant recipients with suspected resistance using next generation sequencing

    PLoS ONE, Vol. 14, Núm. 7

2018

  1. A new cause of false positive voriconazole levels: Watch your collection tubes!

    Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, Vol. 1092, pp. 328-331

  2. Endemic fungal infection recommendations for solid-organ transplant recipients and donors

    Transplantation, Vol. 102, Núm. 2S, pp. S52-S59

2017

  1. Candida guilliermondii complex is characterized by high antifungal resistance but low mortality in 22 cases of candidemia

    Antimicrobial Agents and Chemotherapy, Vol. 61, Núm. 7

  2. Evaluation of the possible influence of trailing and paradoxical effects on the clinical outcome of patients with candidemia

    Clinical Microbiology and Infection, Vol. 23, Núm. 1, pp. 49.e1-49.e8

  3. Impact of fluconazole susceptibility on the outcome of patients with candidaemia: data from a population-based surveillance

    Clinical Microbiology and Infection, Vol. 23, Núm. 9, pp. 672.e1-672.e11

2016

  1. Empirical and targeted therapy of candidemia with fluconazole versus echinocandins: a propensity score–derived analysis of a population-based, multicentre prospective cohort

    Clinical Microbiology and Infection, Vol. 22, Núm. 8, pp. 733.e1-733.e8

2015

  1. A simple prediction score for estimating the risk of candidaemia caused by fluconazole non-susceptible strains

    Clinical Microbiology and Infection, Vol. 21, Núm. 7, pp. 684.e1-684.e9